{"id":620231,"date":"2025-12-24T17:06:21","date_gmt":"2025-12-24T17:06:21","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/620231\/"},"modified":"2025-12-24T17:06:21","modified_gmt":"2025-12-24T17:06:21","slug":"la-bourse-de-paris-termine-sans-changement-atone-avant-noel-24-12-2025-a-1447","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/620231\/","title":{"rendered":"La Bourse de Paris termine sans changement, atone avant No\u00ebl – 24\/12\/2025 \u00e0 14:47"},"content":{"rendered":"

\"Sanofi<\/p>\n

Sanofi a termin\u00e9 \u00e0 -0,39%, \u00e0 81,93 euros, \u00e0 la Bourse de Paris le 24 d\u00e9cembre 2025 ( AFP \/ Ludovic MARIN )<\/p>\n

\n La Bourse de Paris a termin\u00e9 parfaitement stable (-0,00%) mercredi, \u00e0 l’occasion d’une demi-s\u00e9ance tr\u00e8s calme qui conclut une semaine \u00e9court\u00e9e par les f\u00eates de No\u00ebl.\n<\/p>\n

\n L’indice CAC 40 a termin\u00e9 \u00e0 8.103,58 points (-0,27 point), dans un volume d’\u00e9changes tr\u00e8s faible de 485 millions d’euros. Mardi, le CAC 40 a termin\u00e9 en l\u00e9g\u00e8re baisse de 0,21%.\n<\/p>\n

\n La Bourse de Paris a ferm\u00e9 \u00e0 14 heures mercredi, au lieu de 17H30 habituellement, et ne reprendra son activit\u00e9 que lundi.\n<\/p>\n

\n La place parisienne conclut cette semaine en l\u00e9g\u00e8re baisse de 0,59%.\n<\/p>\n

\n \u00ab\u00a0L’ann\u00e9e touche presque \u00e0 sa fin et les traders sont en partie d\u00e9j\u00e0 en vacances. Les investisseurs ont largement remani\u00e9 leurs portefeuilles et beaucoup ont cl\u00f4tur\u00e9 leurs positions pour passer \u00e0 autre chose\u00a0\u00bb, commente Ipek Ozkardeskaya, analyste de Swissquote Bank.\n<\/p>\n

\n Toutefois, \u00ab\u00a0si l’histoire sert de guide, le fameux +rallye de No\u00ebl+, soit les cinq derni\u00e8res s\u00e9ances de l’ann\u00e9e et les deux premi\u00e8res de la nouvelle ann\u00e9e, pourrait g\u00e9n\u00e9rer environ 1,5% de gains suppl\u00e9mentaires\u00a0\u00bb pour les actions mondiales, ajoute l’analyste.\n<\/p>\n

\n Depuis le 1er janvier, le CAC 40 affiche une progression de 9,79%, bien en de\u00e7\u00e0 de la progression de plus de 30% de Milan et de plus de 20% des Bourses de Londres et de Francfort. Madrid s’octroie quant \u00e0 elle un bond de pr\u00e8s de 50% depuis le d\u00e9but de l’ann\u00e9e.\n<\/p>\n


\n Sanofi
\n <\/a>
\n acquiert l’am\u00e9ricain Dynavax<\/p>\n

\n Le g\u00e9ant pharmaceutique fran\u00e7ais Sanofi (-0,39% \u00e0 81,93 euros) a annonc\u00e9 mercredi la signature d’un accord pour acqu\u00e9rir l’entreprise am\u00e9ricaine Dynavax, qui commercialise notamment un vaccin contre l’h\u00e9patite B pour adultes.\n<\/p>\n

\n Selon l’accord, Sanofi lancera une offre publique d’achat en num\u00e9raire pour racheter toutes les actions de Dynavax, soci\u00e9t\u00e9 cot\u00e9e aux Etats-Unis, au prix de 15,50 dollars par action, ce qui valorise l’entreprise \u00e0 environ 2,2 milliards de dollars, selon le laboratoire fran\u00e7ais.\n<\/p>\n

\n
\n Euronext
\n <\/a>
\n CAC40<\/p>\n","protected":false},"excerpt":{"rendered":"Sanofi a termin\u00e9 \u00e0 -0,39%, \u00e0 81,93 euros, \u00e0 la Bourse de Paris le 24 d\u00e9cembre 2025 (…\n","protected":false},"author":2,"featured_media":620232,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[400,398,408,35,405,33,34,1011,27,403,402,399,404,401,406,407],"class_list":{"0":"post-620231","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economie","8":"tag-action-cac-40","9":"tag-bourse-de-paris","10":"tag-boursorama","11":"tag-business","12":"tag-cotations","13":"tag-economie","14":"tag-economy","15":"tag-fr","16":"tag-france","17":"tag-indices-devises","18":"tag-investir","19":"tag-investissement","20":"tag-marche-boursier","21":"tag-sicav","22":"tag-trackers","23":"tag-warrants"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115775641949876549","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/620231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=620231"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/620231\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/620232"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=620231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=620231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=620231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}